Altogether, since Nrf2 pathways are involved in multiple physiological processes during development and in cancer cell chemoresistance, our findings provide a paradigm that may facilitate pharmacological approaches to therapeutic targeting and disease modelling. The gene discussed is NFE2L2; the disease is cancer.